WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $21.4750 and last traded at $21.4750, with a volume of 1900 shares changing hands. The stock had previously closed at $19.78.
Analysts Set New Price Targets
Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Stock Analysis on WUXAY
WuXi AppTec Stock Performance
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Recommended Stories
- Five stocks we like better than WuXi AppTec
- 5 Tech Stocks Holding Their Ground Through the AI Trade Pullback
- The Bitcoin Comeback May Already Be Underway—2 ETFs for Exposure
- Large Caps Across Planes, Tech and Oil Announce Over $10 Billion in Buybacks
- A Sweet Beat and a Wearables Rally Came With Reasons to Pause
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
